🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel Capsule(s) Serving Size
120 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

5 mg (45% DV)
✅ Within RDA (0.5× RDA of 11 mg) 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 5mg UL 40mg
📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)
This product: 80mg
Pygeum africanum bark extract
25 mg
Pumpkin Seed Oil
40 mg
Nettle root extract
75 mg
1 mg
📊 Market median: 10.0mg (35 products) 📚 5 studies (Tier A: 0, B: 2)
This product: 1mg

Other Ingredients

Gelatin Glycerin Water Soybean Oil Beeswax Lecithin Caramel color Water

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Adult Male (18-50 Years) Seniors/Mature (>50 Years) - Men ONLY Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, adults take one softgel capsule, four (4) times daily with meals, or as directed by a health care professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

Contains soy. Manufactured on equipment that processes peanuts. May contain traces of peanuts.

🧪 Formulation Notes

Contains no sugar, salt, dairy, yeast, wheat, corn, preservatives, artificial colors or flavors.

Natural color variations may occur in this product.

Prostate support

Our Saw Palmetto Pygeum Plus softgels are made with the highest quality European standardized extract of saw palmetto and pygeum. Pumpkin seed oil, nettle root extract, lycopene and L-Optizinc work synergistically to enhance the proven benefits of saw palmetto and pygeum.

Quality & potency guaranteed

Additional Information

Store in a cool, dry place and away from direct light.

Product Details

DSLD Entry Date 2024-09-25
Product Type Other Combinations
Form Softgel Capsule
DSLD ID 316708
Data Updated 2026-04-11

Research Evidence

35 Research Sources
52 Avg Quality Score
15 Meta Analysis
11 Systematic Review
7 Rct
1 Narrative Review
1 Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009
View all evidence for Saw Palmetto →

Compare Similar Products

View all Saw Palmetto products →